Lumos Pharma | NLNK - ДОЛГ



ДОЛГ Изменить Дата
Agenus USD 35.54M 2.34M 2025-03
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Celldex Therapeutics USD 2.34M 285K 2025-12
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Eli Lilly USD 42.5B 3.6M 2025-12
Grifols EUR 9.23B 626.05M 2024-12
Incyte USD 39.43M 982K 2026-03
Intrexon USD 0 13.82M 2024-06
Merck USD 49.34B 7.97B 2025-12
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 63.73B 231M 2026-03
Prothena USD 9.08M 699K 2025-09
Sarepta Therapeutics USD 1.04B 210.44M 2025-12